Skip to main content
SpringerLink
Log in

Krankheiten des Kreislaufsystems

  • Chapter
Die ärztliche Begutachtung

  • 5406 Accesses

Zusammenfassung

Die Begutachtung der arteriellen Hypertonie setzt neben der Erfassung des tatsächlichen Blutdruckniveaus und der Differenzialdiagnostik der verschiedenen Hochdruckformen die Kenntnis weiterer kardiovaskulärer Risikofaktoren und hochdruckspezifischer Endorganschäden bzw. relevanter Zusatzerkrankungen voraus. Auf der Basis dieser klinischen Daten kann anhand des durch epidemiologische Studien gut belegten kardiovaskulären Gesamtrisikos eine Risikoabschätzung für jeden Einzelfall vorgenommen werden. Nur selten ist eine endgültige Beurteilung erforderlich, in der Regel kann das Hochdruck-bedingte Risiko durch eine antihypertensive Therapie reduziert werden. Allerdings sind auch evtl. auftretende Nebenwirkungen der antihypertensiven Medikation bei der Beurteilung zu berücksichtigen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Zu 12.1

  1. Arzneimittelkommission der deutschen Ärzteschaft (Hrsg) (2004) Therapieempfehlungen: Arterielle Hypertonie, 2. Aufl.

    Google Scholar 

  2. Bay WH, Hebert LA (1987) The living donor in kidney transplantation. Ann Intern Med 106:719–727

    PubMed  CAS  Google Scholar 

  3. Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  4. Das S, O’Keefe JH (2006) Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr Atheroscler Rep 8:111–118

    Article  PubMed  Google Scholar 

  5. DeMan SA, André JL, Bachmann H (1991) Blood pressure in childhood: pooled findings of six European studies. J Hypertens 9:109–114

    Article  CAS  Google Scholar 

  6. Deutsche Hochdruckliga e. V. DHL – Deutsche Hypertonie-Gesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie. AWMF Register-Nr. 046/001

    Google Scholar 

  7. Fogari R, Zoppi A, Corradi L, et al. (2001) Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study. J Hypertens 19:1021–1027

    Article  PubMed  CAS  Google Scholar 

  8. Hense HW (2004) Epidemiologie der arteriellen Hypertonie. In: Rosenthal J, Kolloch R (Hrsg) Arterielle Hypertonie, 4. Aufl. Springer, Berlin Heidelberg New York, S 42–50

    Chapter  Google Scholar 

  9. Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure (ed) (1997) The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413–2446 [Erratum, Arch Intern Med 1998; 158:573]

    Article  Google Scholar 

  10. Kasiske BL, Ma JZ, Louis TA, et al. (1995) Long-term effects of reduced renal mass in humans. Kidney Int 486–494:814–819

    Google Scholar 

  11. Lucini D, Di Fede G, Parati G, et al (2005) Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension 46:1201–1206

    Article  PubMed  CAS  Google Scholar 

  12. Mancia, G, Laurent, S, Agabiti-Rosei, E, et al. (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121–2158

    Article  PubMed  CAS  Google Scholar 

  13. Powers BJ, Olsen MK, Smith VA ’et al. (2011) Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med 154:781–788

    PubMed  Google Scholar 

  14. Rule AD, Larson TS, Bergstralh EJ, et al. (2004) Using Serum Creatinine to Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease. Ann Intern Med 141:929–937

    PubMed  CAS  Google Scholar 

  15. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 25: 1105–1187

    Article  Google Scholar 

Zu 12.2

  1. Braune S, Lücking CH (1997) Orthostatische Hypotonie. Dtsch Ärztebl 94:A3413–3418

    Google Scholar 

  2. Diehl RR (2003) Posturales Tachykardiesyndrom. In Deutschland bislang zu selten diagnostiziert. Dtsch Ärztebl 100:A2794–2801

    Google Scholar 

  3. Fehrmann HC (2003) 47-jähriger Mann mit „pure autonomic failure“ und Perniziosa. Dtsch Med Wochenschr 128:1347–1350

    Google Scholar 

  4. Hust MH, Heck KF, Keim MW (1999) Kipptisch-Test zur Diagnostik vasovagaler Synkopen. Dtsch Ärztebl 96:A1488–1492

    Google Scholar 

  5. Jordan J, Tank J (2003) Multisystematrophie – Kritisch hinterfragen. Dtsch Ärztebl 100:A-2092

    Google Scholar 

  6. Justl HG, Hahn EG, Maihöfner C, Harsch IA (2010) 33-jähriger Patient mit rezidivierenden Synkopen und orthostatischer Hypotension. Internist 51:788–792

    Article  PubMed  Google Scholar 

  7. Kapoor W (1990) Evaluation and outcome of patients with syncope. Medicine 69:169–175

    Article  Google Scholar 

  8. Klingenheben T (2002) Autonome Dysfunktion und orthostatische Intoleranz. Internist 43:1055–1064

    Article  PubMed  CAS  Google Scholar 

  9. Kopin IJ, Polinsky RJ, Oliver JA, et al. (1983) Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. J Clin Endocrinol Metab 57:632– 637

    Article  PubMed  CAS  Google Scholar 

  10. Malin J-P, Sindern E (1996) Das akute Guillain-Barré-Syndrom. Dtsch Ärztebl 93:A1895–1898

    Google Scholar 

  11. Muscholl M, Scheidt W von (1999) Einige Anmerkungen. Dtsch Ärztebl 96:A3111–3112

    Google Scholar 

  12. Räiha I, Luutonen S, Piha J, et al. (1995) Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med 155:930–935

    Article  PubMed  Google Scholar 

  13. Savage DD, Corwin L, McGee DL, et al. (1985) Epidemiologic features of isolated syncope: The Framingham Study. Stroke 16:626–629

    Article  PubMed  CAS  Google Scholar 

  14. Schroeder C, Vernino S, Birkenfeld AL, et al. (2005) Brief Report: Plasma Exchange for Primary Autoimmune Autonomic Failure. N Engl J Med 353:1585–1590

    Article  PubMed  CAS  Google Scholar 

  15. Tank J (2002) Hypotonie – harmlos oder bedrohlich? Der „Stehtest“ gibt Aufschluss. MMW-Fortschr Med 43:920– 924

    Google Scholar 

  16. Thomaides T, Chaudhuri KR, Maule S, Watson L, Marsden CD, Mathias CJ (1992) The growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet 340:263–266

    Article  PubMed  CAS  Google Scholar 

  17. Wüllner U, Klockgether T (2003) Klinik und Therapie der Multisystematrophie. Dtsch Ärztebl 100: A408–A415

    Google Scholar 

Zu 12.3

  1. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ (1995) Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38:86–96

    Article  PubMed  CAS  Google Scholar 

  2. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274:1049–1057

    Article  PubMed  CAS  Google Scholar 

  3. Bundesministerium für Arbeit und Soziales (Hrsg) (2009) Versorgungsmedizin-Verordnung – VersMedV – Anlage zu § 2 „Versorgungsmedizinische Grundsätze“ in der Fassung vom 17. 12. 2010. In: BGBl.vom 22. 12. 2010, S 2124 – www.bgbl.de CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

    Google Scholar 

  4. Chapman TM, Goa KL (2003) Cilostazol: a review of its use in intermittent claudication. Am J Cardiovasc Drugs 3:117–138

    Article  PubMed  CAS  Google Scholar 

  5. Criqui MH, Denenberg JO, Langer RD, Fronek A (1997) The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 2:221–226

    PubMed  CAS  Google Scholar 

  6. Dawson DL, Cutler BS, Hiatt WR, et al. (2000) A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 109:523–530

    Article  PubMed  CAS  Google Scholar 

  7. De Backer TL, Vander Stichele RH, Warie HH, Bogaert MG (2000) Oral vasoactive medication in intermittent claudication: utile or futile? Eur J Clin Pharmacol 56:199–206

    Article  PubMed  Google Scholar 

  8. De Backer TL, Vander Stichele RH, Bogaert MG (2001) Buflomedil for intermittent claudication. Cochrane Database Syst Rev CD000988, Last assessed as up-to-date: April 28, 2009

    Google Scholar 

  9. Diehm C, Schuster A, Allenberg JR, et al. (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105

    Article  PubMed  CAS  Google Scholar 

  10. Dormandy JA, Heeck L, Vig S (1999) The fate of patients with critical leg ischemia. Semin Vasc Surg 12:142–147

    PubMed  CAS  Google Scholar 

  11. Gardner AW, Poehlman ET (1995) Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 274:975–980

    Article  PubMed  CAS  Google Scholar 

  12. Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295: 547–553

    Article  PubMed  CAS  Google Scholar 

  13. Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608–1621

    Article  PubMed  CAS  Google Scholar 

  14. Kaminski M, Bourgine M, Zins M, Touranchet A, Verger C (1997) Risk Factors for Raynaud’s Phenomenon among Workers in Poultry Slaughterhouses and Canning Factories. Int J Epidemiol 26:371–380

    Article  PubMed  CAS  Google Scholar 

  15. Lawall H, Diehm C, Pittrow P (2009) Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). Vasa 38(S/75):1–72

    Google Scholar 

  16. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H (2002) The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 40:472–479

    Article  PubMed  Google Scholar 

  17. Murabito JM, D’Agostino RB, Silbershatz H, Wilson WF (1997) Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44–49

    Article  PubMed  CAS  Google Scholar 

  18. O’Hare AM, Glidden DV, Fox CS, Hsu CY (2004) High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation 109:320–323

    Article  PubMed  Google Scholar 

  19. Ouriel K (2001) Peripheral arterial disease. Lancet 358:1257–1264

    Article  PubMed  CAS  Google Scholar 

  20. Pande RL et al. (2011) Secondary Prevention and Mortality in Peripheral Artery Disease. National Health and Nutrition Examination Stydy, 1999 to 2004. Circulation 124:17–23

    Article  PubMed  Google Scholar 

  21. Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481–2485

    Article  PubMed  CAS  Google Scholar 

  22. Rutherford RB, Baker JD, Ernst C, et al. (1997) Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 26:517–538

    Article  PubMed  CAS  Google Scholar 

  23. Schoop W (1975) Praktische Angiologie. Thieme, Stuttgart

    Google Scholar 

  24. Scott DGI, Watts RA (2000) Classification and Epidemiology of the Vasculitides. CPD Rheumatology 1:87–93

    Google Scholar 

  25. Smith FB, Bradbury AW, Fowkes FGR (2000) Intravenous naftidrofuryl for critical limb ischaemia (Cochrane Review). The Cochrane Database of Systematic Reviews 2000, Issue 2. Art No: CD002070. DOI: 10.1002/ 14651858.CD002070

    Google Scholar 

  26. Sorenson KE, Kristensen IB, Celermajer DS (1997) Atherosclerosis in the human brachial artery. J Am Coll Cardiol 29:318–322

    Article  Google Scholar 

Zu 12.4

  1. Anderson FA, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–16

    Article  PubMed  Google Scholar 

  2. Callam MJ (1994) Epidemiology of varicose veins. Br J Surg 81:167–173

    Article  PubMed  CAS  Google Scholar 

  3. Fowkes FG, Evans CJ, Lee AJ (2001) Prevalence and risk factors of chronic venous insufficiency. Angiology 52 (Suppl 1):S5–S15

    Article  PubMed  Google Scholar 

  4. Mörl H (1989) Gefäßkrankheiten in der Praxis. Edition Medizin, VCH, Weinheim

    Google Scholar 

  5. White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:I4–8

    Article  PubMed  Google Scholar 

Zu 12.5

  1. Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, Bosanquet N, Mortimer PS (2003) Lymphoedema; an underestimated health problem. Quart J Med 96:731–738

    Article  CAS  Google Scholar 

  2. Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P (2003) Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Austr New Zeal J Obstet Gynaecol 43:148–151

    Article  Google Scholar 

  3. Sitzia J, Woods M, Hine P, Williams A, Eaton K, Green G (1998) Characteristics of new referrals to twenty-seven lymphoedema treatment units. Eur J Cancer Care 7:255–262

    Article  CAS  Google Scholar 

  4. Werngren-Elgstrom M, Lidman D (1984) Lymphoedema of the lower extremity after surgery and radiotherapy for cancer of the cervix. Scand J Plast Reconst Surg Hand Surg 28:289–293

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St.-Walburga-Krankenhaus GmbH, Medizinische Fakultät Essen (AöR), Schederweg 12, 59870, Meschede, Deutschland

    Franz Weber Prof. Dr. med.

  2. Park-Klinikum, Herbert-Heilmann-Allee 44, 79189, Bad Krozingen, Deutschland

    Gerd Bönner Prof. Dr. med.

Authors
  1. Franz Weber Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerd Bönner Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität Frankfurt am Main, Pulheim, Deutschland

    Jürgen Fritze Prof. Dr.

  2. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin, Deutschland

    Friedrich Mehrhoff Dr. jur.

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weber, F., Bönner, G. (2012). Krankheiten des Kreislaufsystems. In: Fritze, J., Mehrhoff, F. (eds) Die ärztliche Begutachtung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21081-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21081-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21080-8

  • Online ISBN: 978-3-642-21081-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation